MARKET

CHGCF

CHGCF

Chugai Pharmaceu
OTCPK
46.20
NaN%
Closed 09:30 07/02 EDT
OPEN
--
PREV CLOSE
45.79
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
64.01
52 WEEK LOW
6.37
MARKET CAP
76.03B
P/E (TTM)
26.69
1D
5D
1M
3M
1Y
5Y
1D
Chugai Pharmaceutical Co (CHGCF) Gets a Buy from Macquarie
TipRanks · 3d ago
Chugai’s Immunotherapy Combo Trial Reaches Completion: What the Latest Update Means for Investors
TipRanks · 06/18 16:31
Goldman Sachs upgrades Chugai Pharmaceutical Co (CHGCF) to a Buy
TipRanks · 06/15 09:41
Chugai Pharmaceutical Co (CHGCF) Gets a Hold from Nomura
TipRanks · 06/03 11:19
Mizuho Securities Keeps Their Hold Rating on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 05/29 10:21
J.P. Morgan Keeps Their Buy Rating on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 05/27 10:35
Bank of America Securities Reaffirms Their Hold Rating on Chugai Pharmaceutical Co (CHGCF)
TipRanks · 05/26 10:33
Analysts Offer Insights on Healthcare Companies: Chugai Pharmaceutical Co (OtherCHGCF), Liquidia Technologies (LQDA) and Health Catalyst (HCAT)
TipRanks · 05/12 10:20
More
About CHGCF
Chugai Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Webull offers Chugai Pharmaceutical Co Ltd stock information, including OTCPK: CHGCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHGCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CHGCF stock methods without spending real money on the virtual paper trading platform.